跳至主要内容
临床试验/NCT04253171
NCT04253171已完成不适用

Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions Before Stent Implantation - a Nationwide Randomized Trial (BALI)

Herlev and Gentofte Hospital18 个研究点 分布在 4 个国家目标入组 200 人开始时间: 2020年1月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
18
主要终点
Number of patients with combined outcome of strategy failure

研究概览

简要总结

Severely calcified coronary stenoses are difficult to treat with percutaneous coronary intervention (PCI) using current techniques and there is little specific evidence on how to best treat these cases. It is hypothesized that balloon lithoplasty is superior to conventional balloons for lesion preparation of severely calcified coronary lesions before stent implantation in terms of procedural failure and 1-year target vessel failure.

详细描述

Severely calcified coronary stenoses are difficult to treat with percutaneous coronary intervention (PCI) using current techniques. Severe calcifications make it difficult to sufficiently prepare lesions before stenting, to advance stents, and to achieve full stent expansion. There is increased risk of vessel dissection and perforation with angioplasty on severely calcified lesions, and long-term outcomes of PCI are adversely affected. Because severely calcified lesions are often excluded from interventional studies, there is little specific evidence on how to best treat these cases. Only a few randomized studies have specifically explored this question, focusing on the use of rotational atherectomy

Recently, the technique of balloon-based lithoplasty was made commercially available. With this technique, calcifications are cracked with the creation of high-frequency pressure oscillations in a special angioplasty balloon. Standard techniques are used to deliver and dilate the balloon. The method was developed for treatment of otherwise non-dilatable lesions, and first reported results have been encouraging. The lithoplasty device used in the current study (Shockwave IVL, Shockwave Medical, CA, USA) has received CE-mark and post-approval safety has recently been confirmed for treatment of severely calcified coronary lesions in patients.

Besides obvious benefits in non-dilatable lesions for which interventional cardiologists have few other options, it is possible this technique could change the way all severely calcified lesions are treated. Balloon lithoplasty could theoretically crack plates of calcium in the vessel wall in an orderly fashion, which could lead to safer and quicker preparation of severely calcified lesions. Furthermore, a better softening of vessel wall calcium could allow full and symmetric expansion of coronary stents, which could lead to better long-term stent patency.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

The primary outcome will be assessed by a blinded clinical events adjudication committee and by a blinded OCT core laboratory analysis.

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years and < 90 years
  • Stable coronary heart disease or non-ST elevation acute coronary syndrome
  • PCI planned in severely calcified, non-occluded, de-novo lesion in native vessel. Definition of severe calcifications (minimum 1 of 3 (i-iii)); i. Angiography: Radioopacities of the vessel wall visible on cine images before contrast injection on both sides of the vessel lumen in more than one projection. ii. OCT (before lesion preparation): Maximum calcium 1) angle >180 degrees AND 2) thickness 0.5mm, AND 3) longitudinal length >5m m. iii. IVUS (before lesion preparation): Maximum calcium angle >270 degrees.
  • Functional evidence of ischemia (non-invasive stress test or fractional flow reserve) in the target vessel territory or stenosis ≥ 90% by visual estimate
  • Target vessel reference diameter visually estimated at 2.5-4 mm with ability to pass a 0.014" guidewire across lesion
  • Ability to tolerate dual antiplatelet therapy
  • Informed consent
  • Angiographic exclusion criteria:
  • Unprotected left main stenosis
  • Chronic total occlusion
  • Severely calcified bifurcated lesion with expected need to use two stent technique
  • Coronary artery dissection
  • Clinical exclusion criteria
  • ST-segment elevation acute myocardial infarction
  • Planned later revascularization in non-study lesions
  • Planned cardiovascular intervention within 30 days after study intervention
  • Clinical instability including decompensated heart disease
  • Life expectancy of less than 1 year
  • Active peptid ulcer or upper gastrointestinal bleeding within 6 months
  • Ongoing systemic infection
  • Paraclinical exclusion criteria
  • Left ventricular ejection fraction <35 %
  • Renal function with eGFR <30 mL/min
  • Pregnant or nursing

排除标准

  • 未提供

结局指标

主要结局

Number of patients with combined outcome of strategy failure

时间窗: 1 year

Failed stent delivery, residual area stenosis ≥ 20% (OCT-assessed) after PCI, or target vessel failure. Residual area stenosis will be defined as \[1 - in-stent minimal lumen area/reference area\]. The reference area will be calculated by averaging the proximal and distal reference areas, which will be determined by measuring the lumen contours on most healthy-looking frame of the final OCT in the 0-5 mm edge segments. If a reference cannot be measured on the final OCT, it will be measured on a pre-stent OCT or by using quantitative coronary angiography if pre-stent OCT is unavailable. Target vessel failure will be defined as cardiac death, target vessel-related myocardial infarction, or clinically driven target vessel revascularization). Failed or no stent delivery is defined as failure to deliver and deploy 1 or more coronary stents to cover the intended length of the intended target lesion.

次要结局

  • Number of patients with composite and components of in-hospital major adverse cardiac events (MACE)(In-hospital)
  • Number of patients with composite and components of major adverse cardiac events (MACE)(1 year)
  • Number of patients with in-hospital procedure-related adverse events(In-hospital)
  • Number of patients with components of the primary outcome(1 year)
  • Number of patients with components of target vessel failure(1 year)
  • OCT outcomes at 1 year procedure(1 year)
  • OCT outcomes at index procedure(During procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Niels Thue Olsen

Primary Investigator

Herlev and Gentofte Hospital

研究点 (18)

Loading locations...

相似试验